Viatris’ (VTRS) Q4 earnings might have gained from the solid performance of Lipitor, Influvac, Viagra and EpiPen.
Category archives: Stocks
Vale (VALE) to Report Q4 Earnings: What’s in the Cards?
Vale’s (VALE) fourth-quarter results are likely to reflect lower iron ore production and iron ore prices as well as higher diesel and freight costs.
Why NetApp (NTAP) Might Surprise This Earnings Season
NetApp (NTAP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Should You Buy Curtiss-Wright (CW) Ahead of Earnings?
Curtiss-Wright (CW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Skillz (SKLZ) to Report Q4 Earnings: What’s in the Offing?
Skillz (SKLZ) fourth-quarter 2021 results are likely to reflect benefits from increased paying monthly active users (MAU).
What’s in the Offing for Planet Fitness’ (PLNT) Q4 Earnings?
Planet Fitness’ (PLNT) fourth-quarter 2021 results are likely to reflect benefits from robust equipment revenues.
Is Cinedigm a Buy Under $1?
Currently trading at less than $1, the shares of leading entertainment content and streaming channels provider Cinedigm (CIDM) have garnered significant investor attention lately due to the company’s robust growth…
Autodesk (ADSK) to Report Q4 Earnings: What’s in the Offing?
Though Autodesk’s (ADSK) Q4 result is likely to have benefited from continued strong demand for its software products, supply chain disruptions might have negatively hurt sales growth.
Daimler’s (DDAIF) Mercedes-Benz Set for Major EV Breakthrough
Daimler’s (DDAIF) Mercedes-Benz, with its newly launched AMG EQE model, is set to gather steam in the EV domain.
Should You Buy Goodyear Tire & Rubber on the Dip?
The shares of one of the world’s largest tire manufacturers, Goodyear Tire & Rubber (GT), have plunged in price on the company’s disappointing financial guidance. However, according to a J.P….